arrow
返回

Peptide-based delivery to bone

delete2012-09-01
delete61
PRE
AI
K
Kazuhiro Aoki *
N
Neil Alles
N
Niroshani S. Soysa
K
Keiichi Ohya
DOI:10.1016/j.addr.2012.05.017delete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Peptides are attractive as novel therapeutic reagents, since they are flexible in adopting and mimicking the local structural features of proteins. Versatile capabilities to perform organic synthetic manipulations are another unique feature of peptides compared to protein-based medicines, such as antibodies. On the other hand, a disadvantage of using a peptide for a therapeutic purpose is its low stability and/or high level of aggregation. During the past two decades, numerous peptides were developed for the treatment of bone diseases, and some peptides have already been used for local applications to repair bone defects in the clinic. However, very few peptides have the ability to form bone themselves. We herein summarize the effects of the therapeutic peptides on bone loss and/or local bone defects, including the results from basic studies. We also herein describe some possible methods for overcoming the obstacles associated with using therapeutic peptide candidates. (C) 2012 Elsevier B.V. All rights reserved.
Keyword:
RANKL (receptor activator of NF-kappa B ligand)
Antagonist
Bone resorption inhibitory peptide
Bone formation stimulatory peptide
Cholesterol-bearing pullulan (CHP) nanogel
BMP
Collagen
Thrombin
Bone-targeting peptide
Half-life
Stability
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Advanced Drug Delivery Reviews 封面图
Advanced Drug Delivery Reviews
IF:
17.6
论文数:
4.5K
被引数:
5.1W

机构

I
Institute of Science Tokyo
学者数:
3.2W
论文数: 2.7W
被引数: 117
引用论文

引用论文

Current Role of PCNL in Pediatric Urolithiasis
err2014-06-05
err0
PREAI
errRavindra B. Sabnis; Jaspreet S. Chhabra; Arvind P. Ganpule; Sachin Abrol; Mahesh R. Desai
err分享
err收藏
A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
err2012-01-29
err381
PREAI
errZhang, Ge; Guo, Baosheng; Wu, Heng; Tang, Tao; Zhang, Bao-Ting; Zheng, Lizhen; He, Yixin; Yang, Zhijun; Pan, Xiaohua; Chow, Heelum; To, Kinwah; Li, Yaping; Li, Dahu; Wang, Xinluan; Wang, Yixiang; Lee, Kwongman; Hou, Zhibo; Dong, Nan; Li, Gang; Leung, Kwoksui; Hung, Leungkim; He, Fuchu; Zhang, Lingqiang; Qin, Ling
err分享
err收藏
Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo
err2004-05-23
err511
PREAI
errJimi, E; Aoki, K; Saito, H; D'Acquisto, F; May, MJ; Nakamura, I; Sudo, T; Kojima, T; Okamoto, F; Fukushima, H; Okabe, K; Ohya, K; Ghosh, S
err分享
err收藏
Update on bone-modifying agents in metastatic breast cancer
err2011-05-24
err10
PREAI
errSuva, Larry J.; Brander, Brooke E.; Makhoul, Issam
err分享
err收藏
学者 查看更多内容